Oncolytics Biotech Inc. announced the appointment of Leonard Kruimer, MBA, CPA, to Oncolytics' Board of Directors. Mr. Kruimer has more than 30 years of experience in corporate finance, planning and strategy, including 20 years in senior management positions in private and publicly listed biotechnology and life science companies. Notably, Mr. Kruimer served as CFO and Executive Committee Member of the Netherlands- based vaccine company Crucell from 1998 through 2011, and an integral part of the corporate sale to Johnson & Johnson for $2.3 billion.